- Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract. Dodd, P.M., McCaffrey, J.A., Hilton, S., Mazumdar, M., Herr, H., Kelly, W.K., Icasiano, E., Boyle, M.G., Bajorin, D.F. J. Clin. Oncol. (2000)